본문

  1. Home
19 Results:UU:VOL49NO220118 0.124 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
11
The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat
The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat
Campbell, G. M., | Elsevier Inc | 2011 ,
12
Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts
Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts
Naot, D., | Elsevier Inc | 2011 ,
13
Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone
Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone
Syed, F. A., | Elsevier Inc | 2011 ,
14
Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women
Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women
Modder, U. I., | Elsevier Inc | 2011 ,
15
Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women
Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women
Scheid, J. L., | Elsevier Inc | 2011 ,
16
Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it
Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it
Saxon, L. K., | Elsevier Inc | 2011 ,
17
In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption
In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption
Dong, X. N., | Elsevier Inc | 2011 ,
18
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
Ominsky, M. S., | Elsevier Inc | 2011 ,
19
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
Kostenuik, P. J., | Elsevier Inc | 2011 ,
처음이전12마지막